Canada markets close in 1 hour 9 minutes

Abrdn Life Sciences Investors (HQL)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
13.33+0.25 (+1.91%)
As of 02:50PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 357.74M
Enterprise Value N/A
Trailing P/E 16.56
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)15.73
Price/Book (mrq)0.89
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.72
52-Week Change 3-5.76%
S&P500 52-Week Change 323.10%
52 Week High 314.37
52 Week Low 311.34
50-Day Moving Average 313.43
200-Day Moving Average 313.07

Share Statistics

Avg Vol (3 month) 399.63k
Avg Vol (10 day) 398.91k
Shares Outstanding 527.35M
Implied Shares Outstanding 627.35M
Float 8N/A
% Held by Insiders 10.01%
% Held by Institutions 135.79%
Shares Short (Apr 15, 2024) 419.09k
Short Ratio (Apr 15, 2024) 40.23
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.07%
Shares Short (prior month Mar 15, 2024) 429.43k

Dividends & Splits

Forward Annual Dividend Rate 41.33
Forward Annual Dividend Yield 410.17%
Trailing Annual Dividend Rate 31.30
Trailing Annual Dividend Yield 39.94%
5 Year Average Dividend Yield 49.13
Payout Ratio 4162.03%
Dividend Date 3Dec 31, 2018
Ex-Dividend Date 4Feb 21, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2022
Most Recent Quarter (mrq)Mar 31, 2023

Profitability

Profit Margin 156.45%
Operating Margin (ttm)-48.76%

Management Effectiveness

Return on Assets (ttm)-0.32%
Return on Equity (ttm)1.28%

Income Statement

Revenue (ttm)3.51M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)34.40%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)5.5M
Diluted EPS (ttm)0.79
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)822
Total Cash Per Share (mrq)0
Total Debt (mrq)9.33M
Total Debt/Equity (mrq)2.21%
Current Ratio (mrq)0.27
Book Value Per Share (mrq)16.12

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A